BTRX-335140
CAS No. 2244614-14-8
BTRX-335140( CYM-53093 )
Catalog No. M24021 CAS No. 2244614-14-8
BTRX-335140 is a potent and selective, orally active κ opioid receptor (KOR) antagonist, has antagonist activity for κOR, μOR and δOR with IC50 values of 0.8 nM, 110 nM, and 6500 nM, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 282 | In Stock |
|
| 2MG | 149 | In Stock |
|
| 5MG | 250 | In Stock |
|
| 10MG | 407 | In Stock |
|
| 25MG | 841 | In Stock |
|
| 50MG | 1349 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBTRX-335140
-
NoteResearch use only, not for human use.
-
Brief DescriptionBTRX-335140 is a potent and selective, orally active κ opioid receptor (KOR) antagonist, has antagonist activity for κOR, μOR and δOR with IC50 values of 0.8 nM, 110 nM, and 6500 nM, respectively.
-
DescriptionBTRX-335140 is a potent and selective, orally active κ opioid receptor (KOR) antagonist, has antagonist activity for κOR, μOR and δOR with IC50 values of 0.8 nM, 110 nM, and 6500 nM, respectively. BTRX-335140 can distribute well into the CNS. ADMET (absorption, distribution, metabolism, excretion, and toxicity) . BTRX-335140 endows with favorable in vitro ADMET and in vivo pharmacokinetic profiles and medication-like duration of action in rats.
-
In VitroNavacaprant (BTRX-335140) (0-10 μM; 4 h) shows selective antagonist activity towards Kappa Opioid Receptor. Cell Viability Assay Cell Line:OPRK1-BLA U2OS cells Concentration:0-10 μM Incubation Time:4 hours Result:Exibited antagonist activity to KOR, DOR and MOR with IC50 values of 0.8, 110 and 6500 nM respectively, and showed selective antagonist activity to KOR.
-
In VivoNavacaprant (BTRX-335140) (0.01-3 mg/kg; p.o. once) reduces U69,593- stimulated plasma prolactin secretion to levels of without U69,593 treatment.Navacaprant (BTRX-335140) (1 mg/kg; i.p. once) blocks U-50488-induced antinociception from hot water.Animal Model:Rat PRL model Dosage:0.01, 0.03, 0.1, 0.3, 1 and 3 mg/kg Administration:Oral gavage; 0.01-3 mg/kg onceResult:Effectively decreased the high level prolactin caused by U69,593 even at a dosage of 0.1 mg/kg.Animal Model:Adult male ICR mice with tail dipped into 50°C hot water Dosage:1 mg/kg Administration:Intraperitoneal injection; 1 mg/kg once Result:Blocked the U-50488-induced antinociception at 1 h but not at 24 h pretreatment time and showed a medication-like duration of action in blocking the KOR.
-
SynonymsCYM-53093
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
Recptorδ-opioid receptor|κ-opioid receptor|μ-opioid receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2244614-14-8
-
Formula Weight453.55
-
Molecular FormulaC25H32FN5O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:16.67 mg/mL (36.75 mM; Need ultrasonic)
-
SMILESCCc1cc2c(C)c(-c3nc(C)no3)c(N(CC3)CCC3NC3CCOCC3)nc2c(F)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Guerrero M, et al. Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140). J Med Chem. 2019 Feb 28;62(4):1761-1780.
molnova catalog
related products
-
PL 017
Selective μ opioid receptor agonist (IC50 values are 5.5 and > 10000 nM for inhibition of 125I-FK 33,824 and 125I-DADLE binding to μ and δ sites respectively). Produces naloxone-reversible analgesia, catalepsy and hyperthermia following central administration in rats in vivo.
-
IPAG
IPAG is a potent σ-receptor antagonist (pKi=4.3). IPAG can induce cell apoptosis.
-
Enadoline
Enadoline (CI 977;PD 129290) is a potent, selective κ-opioid receptor (KOR) agonist with Ki of 0.11 nM.
Cart
sales@molnova.com